Presentation is loading. Please wait.

Presentation is loading. Please wait.

Glomerular Diseases In Pediatrics.

Similar presentations

Presentation on theme: "Glomerular Diseases In Pediatrics."— Presentation transcript:

1 Glomerular Diseases In Pediatrics

2 Glomerular diseases Tubulointerstitial Vascular disease

3 Glomerular Diseases Primary (renal disease alone)
Secondary (due to systemic autoimmune disorders, vasculitis, or infection, drugs)

Many causes of glomerular disease. Urine sediment and the degree of proteinuria: Two clinical patterns: Nephrotic Nephritic

5 Nephritic Pattern Active urine sediment:
Hematuria: Presence of RBC (Some acanthocytes) Occasionally WBC ± RBC cast ± mixed cellular casts (Granular , RBC and other cellular casts) variable degrees of proteinuria, ranging from normal protein excretion to the nephrotic range (ie, both nephritic and nephrotic). Acanthocytes are considered virtually diagnostic of glomerular hematuria



8 Nephrotic Pattern Proteinuria that is usually above 3.5 g/day
lipiduria fatty casts but few cells or few casts. Some microscopic hematuria Red cell casts are usually not seen (when present, may result from a concurrent glomerulonephritis as has been described in diabetic nephropathy.)


10 INITIAL EVALUATION Patients with Glomerulonephritis
Clinical features  Urinalysis and urinary protein Renal function  Patients with Glomerulonephritis Patients with Nephrotic Syndrome

11 Mild glomerulonephritis Moderate to severe glomerulonephritis
Classification of Glumelular Diseases Mild glomerulonephritis Moderate to severe glomerulonephritis Nephrotic syndrome without a nephritic sediment

12 Mild glomerulonephritis
Mild glomerulonephritis is defined as a nephritic sediment in patients who have a normal or near normal GFR and do not have the nephrotic syndrome. Less than 15 years 15 to 40 years Greater than 40 years


14 Moderate to severe glomerulonephritis
Moderate to severe glomerulonephritis is defined as a nephritic sediment in patients who have a reduced GFR and/or nephrotic syndrome. Less than 15 years 15 to 40 Greater than 40 years


16 Nephrotic syndrome without a nephritic sediment
Patients with nephrotic syndrome without a nephritic sediment do not have red cell casts but may have mild hematuria. Less than 15 15 to 40 years Greater than 40 years


18 Clinical Features Nephrotic syndrome Glomerulonephritis edema,
usually present only with edema. In severe cases: anasarca with ascites, and respiratory distress caused by pleural effusions. Glomerulonephritis edema, hypertension, reddish brown to brown colored urine, and a rising serum creatinine.

19 Diagnosis When approaching a patient with apparent glomerular disease,
the urinalysis, urinary patterns (nephrotic and nephritic) the degree of proteinuria the estimated GFR and patient age help to identify the most likely causes; allow the differential diagnosis to be substantially narrowed However, confirmation by renal biopsy is usually required.

20 Nephrotic Syndrome

21 Nephrotic Syndrome 4 clinical features, but the first two are used diagnostically: Nephrotic range proteinuria — Urinary protein excretion greater than 50 mg/kg per day Hypoalbuminemia — Serum albumin concentration less than 3 g/dL (30 g/L) Edema Hyperlipidemia

22 Nephrotic Syndrome… Nephrotic syndrome in children is classified into three categories: Primary nephrotic syndrome, which refers to nephrotic syndrome in the absence of an identifiable systemic disease Secondary nephrotic syndrome, which refers to nephrotic syndrome in the presence of an identifiable systemic disease. Congenital and infantile nephrotic syndrome.

23 Nephrotic Syndrome… Idiopathic nephrotic syndrome
The most common form of childhood nephrotic syndrome: Representing more than 90 % of cases between years of age and 50 % >10 years of age.

24 Nephrotic Syndrome… Minimal change disease (MCD) is the most commonly seen histopathology of childhood nephrotic syndrome; renal biopsy: Minimal change disease (MCD) — 77 percent Membranoproliferative glomerulonephritis (MPGN) — 8 percent Focal segmental glomerulosclerosis (FSGS) — 7 percent Proliferative glomerulonephritis — 2 percent Mesangial proliferation — 2 percent Focal and global glomerulosclerosis — 2 percent Membranous glomerulonephropathy — 2 percent

25 Nephrotic Syndrome… Treatment: Major Treatment
Treatment of Complications

26 Nephrotic Syndrome… The vast majority of patients with MCD (>90 percent) respond to steroid therapy. MCD can be clinically differentiated from those with other causes of nephrotic syndrome.

27 Clinical findings at presentation accurately differentiated children with MCD from those with other glomerular pathology: Age younger than six years of age Absence of hypertension Absence of hematuria Normal complement levels Normal renal function

28 Based upon these observations, an initial trial of steroid therapy is generally administered to children who are likely to have MCD based upon clinical diagnosis, thereby avoiding renal biopsy.

29 Steroid-responsive nephrotic syndrome:
The majority (>90%) of children with idiopathic nephrotic syndrome are steroid-responsive (also referred to as steroid-sensitive nephrotic syndrome). In these patients, the most likely histologic lesion is MCD, although some patients with FSGS will also respond to steroid therapy. Patients who are steroid-responsive have a favorable long-term outcome with a very low risk of chronic renal disease. Steroid-resistant nephrotic syndrome : Approximately 20 percent of all children with idiopathic nephrotic syndrome will not respond to steroid therapy. The response rate is better in younger children, who are much more likely to have MCD. (Renal biopsy)

30 Time to response  Most patients who respond to steroid therapy will do so within the first four weeks of therapy

31 Initial therapy: Initial prednisone therapy of 2 mg/kg per day for six weeks, followed by alternate day prednisone of 1.5 mg/kg for an additional six weeks. First relapse/Infrequent relapse: Prednisone therapy of 2 mg/kg per day until the urine protein tests are negative or trace for three consecutive days, followed by alternate day prednisone of 1.5 mg/kg for four weeks. Frequent relapses: oral cyclophosphamide, cyclosporine, and mycophenolate mofetil Steroid-dependent disease Steroid-resistant disease

32 Symptomatic management of nephrotic syndrome in children
Complications Edema Hypercoagulability Hypoalbuminemia Increased risk of infections Hyperlipidemia Hypertension

33 EDEMA Edema increases gradually and becomes detectable when fluid retention exceeds 3 to 5 percent of body weight. Typically, periorbital edema is noted first and is often misdiagnosed as a manifestation of allergy. The edema can become generalized and massive (anasarca) resulting in peripheral edema, ascites, umbilical or inguinal hernias, scrotal or vulva swelling, and/or pleural effusions.


35 EDEMA… Salt restriction Diuretics
Because of the potential for serious complications, diuretic management should be supervised by a nephrologist who has expertise in treating children with NS. Furosemide and albumin — Patients with anasarca (generalized and massive edema) may be treated with furosemide (1 to 2 mg/kg per dose) in combination with albumin (0.5 to 1 g/kg infused over four hours).

36 EDEMA… Despite the marked increase in extracellular fluid volume, some children with nephrotic syndrome, primarily those with MCD, present with or develop signs of a decrease in effective circulating volume, such as tachycardia, peripheral vasoconstriction, oliguria, decreased glomerular filtration rate, elevation of plasma renin aldosterone, and norepinephrine. In such children, a further insult such as diuretic therapy, sepsis, or diarrhea can lead to hypotension and rarely shock.

37 EDEMA… Albumin raises the intravascular oncotic pressure and thereby protects the intravascular compartment against volume contraction. Albumin infusion also increases protein-binding of furosemide, which improves the rate of delivery to the kidney resulting in increased renal salt excretion.

38 EDEMA… Fluid restriction
Although there is debate on the role of fluid restriction, initial restriction of fluid intake to an equivalent volume of the patient's insensible losses plus his/her urine output will result in stabilizing the patient's weight without further accumulation of edema.

39 Hypercoagulability Nephrotic patients with severe hypoalbuminemia are at risk for thromboembolic complications. Preventative measures include mobilization, avoidance of hemoconcentration resulting from hypovolemia, and early treatment of sepsis or volume depletion. Most clinicians do not give prophylactic warfarin therapy initially. However, a few will initially treat high-risk patients with albumin concentration of less than 2 g/dL (20 g/L), a fibrinogen level of more than 6 g/L, or an antithrombin III level less than 70 percent of normal. Alternatively, high-risk patients can be treated with low-dose aspirin or dipyridamole, although there are no controlled trials that demonstrate their efficacy in thrombus prevention in children with NS.

40 Hypercoagulability… Heparin is given if thrombi do occur. However, the dose necessary to obtain a therapeutic effect is often greater than normal because of decreased antithrombin III, a cofactor required for heparin activity. In patients with previous thromboembolic complications, start treatment anticoagulation therapy if the patient remains nephrotic, which places them at continued risk for thrombosis.

41 Infections Bacterial — Nephrotic children are at increased risk of developing infection (eg, peritonitis, pneumonia, and sepsis) due to encapsulated bacteria, in part due to reduced serum concentrations of immunoglobulin, decreased cellular immunity, and the administration of immunosuppressive therapy. The most common agent is streptococcus pneumoniae followed by Escherichia coli. Varicella 

42 Hyperlipidemia Persistent hyperlipidemia is a risk factor for atherosclerosis and may play a role in the progression of chronic renal failure. The lipid abnormalities induced by the NS reverse with remission. The optimal treatment of hyperlipidemia in children with persistent NS is unknown. In children with NS, statin therapy based on limited short-term observational data is effective and safe in reducing total and LDL cholesterol, and triglyceride levels. Nevertheless, statins should be used with caution until controlled studies are performed.

43 Hyperlipidemia… Based on evidence as well as data on the benefit of statin therapy in children with familial hypercholesterolemia, Treat children who remain persistently nephrotic and have hyperlipidemia with statin therapy. LDL apheresis with steroid therapy has been proposed in patients with hyperlipidemia and refractory nephritic syndrome.

44 Hypertension Children with NS and persistent hypertension are more likely to have chronic kidney disease with poor outcome. As a result, in patients with hypertension, ACE or ARBs are the preferred anti-hypertensive agents because of their potential additive antiproteinuric benefit and ability to slow progression of renal impairment. The maximal anti-proteinuric effect is observed after four weeks ; the antiproteinuric effect can be increased by low salt diet and/or diuretics . Other antihypertensive agents that have been used in children with NS include beta-blockers and calcium channel blockers.

45 Glomerulonephritis

46 INTRODUCTION  Glomerulonephritis (GN) generally presents as a constellation of findings that includes hematuria, edema, and often hypertension. GN is caused by a number of disorders that are all characterized by glomerular injury + inflammation. In some cases, GN may progress to renal failure.


Because the differential diagnosis for GN is broad, using a classification schema is helpful to narrow the causes of childhood GN in a systematic manner. The etiology of glomerulonephritis can be classified by the following methods: Clinical presentation Histopathology The preferred etiologic approach is to use the clinical presentation schema because the histopathologic method requires a biopsy sample.

49 Acute glomerulonephritis Rapidly progressive glomerulonephritis
Classification of glomerulonephritis Acute glomerulonephritis Rapidly progressive glomerulonephritis Recurrent macroscopic hematuria Chronic glomerulonephritis

50 Acute GN  Acute glomerulonephritis (GN) typically presents as: Sudden onset of hematuria (either gross or microscopic) ± proteinuria, decreased GFR, and retention of sodium and water, which usually results in an elevated blood pressure and edema.

51 In children, the most common cause of acute GN is poststreptococcal GN.
Acute nephritis also has been associated with other infectious agents . Other causes of acute GN include secondary GN (eg, Henoch-Schönlein purpura [HSP], nephritis associated with subacute bacterial endocarditis, and shunt nephritis.



54 Poststreptococcal glomerulonephritis in children

55 Poststreptococcal glomerulonephritis (PSGN)
Caused by prior infection with specific nephritogenic strains of group A beta-hemolytic streptococcus.

56 Prognosis PSGN is associated with a variable decline in GFR that is detected by a rise in serum creatinine. Acute renal failure requiring dialysis is uncommon. The prognosis is generally favorable, especially in children, but in some cases, the long-term prognosis is not benign.

57 Clinical Manifestations
Clinical presentation of PSGN varies from asymptomatic, microscopic hematuria to the full-blown acute nephritic syndrome, characterized by red to brown urine, proteinuria (which can reach the nephrotic range), edema, hypertension, and acute kidney injury. There is usually an antecedent history of a group A beta-hemolytic streptococcal (GAS) skin or throat infection. The latent period between GAS infection and PSGN is dependent upon the site of infection: between one and three weeks following GAS pharyngitis and between three and six weeks following GAS skin infection.

58 Clinical Manifestations…
The following symptoms are the most common presenting signs in children: Edema — Generalized edema is present in about two-thirds of patients due to sodium and water retention. In severe cases, fluid overload leads to respiratory distress due to pulmonary edema. Gross hematuria — Gross hematuria is present in about 30 to 50 percent of patients. The urine looks smoky, and tea or coca cola-colored. Hypertension — Hypertension is present in 50 to 90 percent of patients and varies from mild to severe. It is primarily caused by fluid retention. Hypertensive encephalopathy was an uncommon but serious complication. These patients require emergent intervention. Subclinical cases of PSGN are primarily characterized by microscopic hematuria. Such patients were often detected during epidemics.

59 Laboratory findings DIAGNOSIS — PSGN is usually diagnosed based upon clinical findings of acute nephritis and demonstration of a recent group A beta-hemolytic streptococcal (GAS) infection. The clinical findings of acute nephritis include hematuria with or without red blood cell casts, variable degrees of proteinuria, edema, and hypertension. Documentation of a recent GAS infection includes either a positive throat or skin culture or serologic tests (eg, ASO or streptozyme test).

60 MANAGEMENT  There is no specific therapy for PSGN. There is no evidence that aggressive immunosuppressive therapy has a beneficial effect in patients with rapidly progressive crescentic disease. However, patients with more than 30 percent crescents on renal biopsy are often treated with methylprednisolone pulses. Management is supportive and is focused on treating the clinical manifestations of the disease, particularly complications due to volume overload. These include hypertension and, less commonly, pulmonary edema. General measures include sodium and water restriction and loop diuretics. Loop diuretics generally provide a prompt diuresis with reduction of blood pressure and edema. In our practice, intravenous furosemide is given at an initial dose of 1 mg/kg (maximum 40 mg).

61 COURSE Resolution of the clinical manifestations of PSGN is generally quite rapid. A diuresis typically begins within one week, and the serum creatinine returns to the previous baseline by three to four weeks.

62 COURSE… The urinary abnormalities disappear at differing rates.
Hematuria usually resolves within three to six months. Proteinuria also falls during recovery, but at a much slower rate. A mild increase in protein excretion is still present in 15 percent at 3 years, and 2 percent at 7 to 10 years.

63 COURSE… In severe cases with nephrotic range proteinuria, this degree of proteinuria may persist for six months or more, long after the hematuria has disappeared. Patients first seen at this late stage are often thought to have one of the causes of the idiopathic nephrotic syndrome (eg, membranous nephropathy, focal segmental glomerulosclerosis, or minimal change disease).

64 Recurrence Recurrent episodes of PSGN are rare .
This may be due to the long-term persistence of antibodies to nephritis-associated streptococcal antigen.


Download ppt "Glomerular Diseases In Pediatrics."

Similar presentations

Ads by Google